Clinical Trials Logo

Clinical Trial Summary

Nasal patency is an important component of performing exercises because it helps in humidifying, heating and filtering the inhaled air. However, many athletes and exercisers experience difficulty breathing through their nose, which can affect their breathing and performance. Namely, during sports activities and greater physical effort, there is increased air flow, which causes significant dehydration and cooling of the mucous membrane of the upper respiratory system. This dehydration is associated with the release of inflammatory mediators, which can ultimately lead to narrowing of the airways (eg in athletes with asthma). However, in all athletes, regardless of whether they have asthma or not, damage to the airways can occur because during exercise, hyperpnea exposes the respiratory epithelium to increased physical forces and pressure, which leads to the risk of exfoliation of the previously dehydrated epithelial cells of the nose and even their complete separation. Repeated stretching and compression can negatively affect the functionality of the epithelium and, with repeated exposure and damage, lead to structural and functional changes. Rinsing the nose with a hypertonic or isotonic solution of seawater is a potential solution for nasal obstruction because after rinsing, the airflow through the nose improves and symptoms of obstruction are reduced. However, the effects of using nasal lavage solutions along with exercise in elite athletes are not yet known. The potential synergy of exercise and isotonic seawater solution as a nasal spray on airflow and the subjective impression of nasal patency in healthy individuals has not been sufficiently investigated5. Research question What is the effect of an isotonic seawater solution applied as a nasal spray on nasal airflow and the subjective impression of nasal obstruction in healthy athletes? Hypothesis An isotonic seawater solution applied as a nasal spray will improve nasal airflow and the subjective impression of nasal obstruction in healthy athletes.


Clinical Trial Description

Subjects and Methods Participants: 50 healthy adult athletes between the ages of 18 and 35 will be engaged in the research (power analysis with 80% power and an alpha error of 5% shows that 32 subjects in two groups are sufficient). Exclusion criteria: Bacterial or viral acute inflammation of the upper respiratory system, chronic obstruction of one or both nostrils with significant deformation of the septum, surgery on the nose or nasal septum within one month of the start of the study Isotonic seawater: product from the market, Aqua Maris nasal spray (manufacturer JGL, Rijeka), applied in accordance with the approved Instructions for Consumers Study design: A randomized, interventional prospective cohort study. Intervention: The participants will be divided into two groups using the binary coin-toss method (random.org) with similar physical and demographic characteristics. The first group will use an isotonic seawater solution as a nasal spray for 10 days, while the control group will not use such a solution. The group with the isotonic seawater solution applied as a nasal spray will use it at least three times a day, and necessarily before exercise (about 20 minutes before). Outcome measures: The primary outcome measures will be nasal airflow measured with a peak nasal inspiratory flow meter (PNIF) and subjective impression of nasal obstruction symptoms before and after exercise by completing the NOSE questionnaire. The NOSE contains five statements about nasal obstruction, divided on a 4-point Likert scale for each statement. Remark: PNIF meters will be provided by JGL (measurement with them takes < 1 min/athlete) The NOSE questionnaire (abbreviated from Nasal Obstruction Symptom Evaluation) is an internationally recognized and validated scale for assessing the intensity of nasal obstruction. The time points for the collection of measures will be: 1. Day 1: before the start of the research, before the first training session (first interval), respectively: 1. NOSE 2. PNIF 2. Day 1: after the first use of the spray, (within 20 minutes after the first training session - second interval), i.e. after the first training session in the control group, respectively: 1. NOSE 2. PNIF 3. Day 7: after ten days of daily use of the spray, after training (third interval) or after the first training in the control group, respectively: 1. NOSE 2. PNIF Data analysis: 1. Descriptive statistics and inferential statistics will be used to compare outcomes between two groups (no less than 16 participants in the nasal spray group vs. no less than 16 participants without the spray). 2. Each couple from the test group will be joined by a couple from the control group with as similar physical and demographic characteristics as possible. The Wilcoxon signed rank test and the Friedman test for paired samples will be used depending on the distribution of the data. Ethical considerations This study will be conducted in accordance with ethical principles and guidelines (1996 Helsinki Declaration, in accordance with current Croatian regulations, and after approval by the competent hospital ethics committee). Written informed consent will be obtained from all participants. Participants will be informed of the risks and benefits of the study by the examining physician. The confidentiality of the participant's data will be ensured in such a way as to comply with GDPR provisions in accordance with EU and national legislation. Conclusion This study aims to investigate the effects of an isotonic solution of seawater from the Adriatic Sea applied as a nasal spray on: - subjective nasal patency - nasal airflow in healthy athletes. The results of this research could help athletes improve performance by improving nasal airflow and nasal function. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05948800
Study type Interventional
Source University Hospital "Sestre Milosrdnice"
Contact
Status Recruiting
Phase N/A
Start date April 16, 2023
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT04228016 - Efficacy of an Intranasal Stent on Nasal Obstruction at Night N/A
Completed NCT02914236 - Treatment of Nasal Airway Obstruction Using the Aerin Medical Device N/A
Completed NCT02952313 - Spirox Lateraâ„¢ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study N/A
Completed NCT01965457 - Assessment of Adenoidal Obstruction in Children : Clinical Signs Versus Flexible Nasal Endoscopy and Roentgenographic Findings N/A
Completed NCT00850876 - Heated Humidified Continuous Positive Airway Pressure and Nasal Physiology N/A
Completed NCT03156270 - Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction N/A
Active, not recruiting NCT05099263 - The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL) N/A
Recruiting NCT05573919 - VivAer: A Correlation Between Symptom Scores and Objective Findings N/A
Completed NCT03290300 - Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Recruiting NCT04499469 - The Role of Spreader Grafts in Reduction Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Assessment N/A
Not yet recruiting NCT01702103 - Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays Phase 3
Completed NCT04220853 - Changes in Nasal Airflow Parameters After Septoplasty and Turbinoplasty N/A
Completed NCT03456115 - A New Treatment for Mechanical Nasal Obstruction N/A
Completed NCT00793117 - The Effect of Packing in Post Operative Management of FESS Phase 4
Completed NCT02964312 - LATERA-OFFICE Study N/A
Recruiting NCT04150783 - Computational Modeling of Cleft Lip Nasal Deformity and Assessment of Nasal Function and Treatment Outcomes
Completed NCT01506583 - Clinical Evaluation of QFlu Combo Test
Recruiting NCT03925389 - Outcome Analysis in Septorhinoplasty
Recruiting NCT05494346 - Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction N/A